We are live on
!
Find out more
SR
Syntax Research Portfolio holdings
AUM
$137M
1-Year Est. Return
21.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.32%
1 Year Est. Return
+21.22%
3 Year Est. Return
+42.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$4.04M
(-2.8%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-8.48%
Top 10 Holdings %
Top 10 Hldgs %
46.39%
Holding
182
New
7
Increased
31
Reduced
30
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$2.35M |
| 2 |
Zoetis
ZTS
|
+$2.21M |
| 3 |
Willis Towers Watson
WTW
|
+$2.17M |
| 4 |
Palo Alto Networks
PANW
|
+$2.16M |
| 5 |
Accenture
ACN
|
+$2.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$3.4M |
| 2 |
American Tower
AMT
|
+$3.32M |
| 3 |
Newmont
NEM
|
+$3.21M |
| 4 |
Americold
COLD
|
+$2.6M |
| 5 |
Merck
MRK
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.08% |
| 2 | Technology | 19.94% |
| 3 | Healthcare | 5.03% |
| 4 | Industrials | 4.92% |
| 5 | Financials | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Digital Realty Trust
DLR
$69.9B
| – | – |
-15,000
| Closed | -$2.15M |
|
177
iShares China Large-Cap ETF
FXI
$4.28B
| – | – |
-28,249
| Closed | -$1.01M |
|
178
iShares Core MSCI Emerging Markets ETF
IEMG
$165B
| – | – |
-20,095
| Closed | -$1.08M |
|
179
Leidos
LDOS
$16.7B
| – | – |
-15,000
| Closed | -$2.02M |
|
180
Waste Management
WM
$87.5B
| – | – |
-2,098
| Closed | -$486K |
|
181
Weyerhaeuser
WY
$16.6B
| – | – |
-40,000
| Closed | -$1.17M |
|
182
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.27B
| – | – |
-344
| Closed | -$14.4K |
|
Similar funds
CCM
DSC
II
SWP
BCM
MWP
TWM
TPCM
Syntax Research's Q2 2025 Portfolio in Review
As of Q2 2025, Syntax Research held 182 positions worth $141M, down 2.8% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Syntax Research withdrew a net $11.9M in Q2 2025, closing 12 positions and reducing 30 holdings. Its most notable exit was Americold, an estimated $2.6M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Syntax Research opened a new position in Zoetis worth $2.17M.
- Syntax Research's largest Q2 2025 buy was Zoetis: 13,918 shares worth $2.17M.
- Syntax Research added most to Thermo Fisher Scientific in Q2 2025, an estimated $2.35M increase.
- Syntax Research's biggest Q2 2025 reduction was Nutrien, cutting an estimated $3.4M.
- Syntax Research fully exited Americold in Q2 2025, selling an estimated $2.6M.
- Syntax Research's ten largest holdings make up 46% of its $141M portfolio in Q2 2025.
- Syntax Research opened 7 new positions and closed 12 in Q2 2025.
- Syntax Research's portfolio value fell 2.8% quarter-over-quarter to $141M.
Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.